Imperial College London

Professor Amanda Cross

Faculty of MedicineSchool of Public Health

Professor of Cancer Epidemiology
 
 
 
//

Contact

 

+44 (0)20 7594 3338amanda.cross

 
 
//

Assistant

 

Mr Will Kay +44 (0)20 7594 3350

 
//

Location

 

Room 1089Queen Elizabeth the Queen Mother Wing (QEQM)St Mary's Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Caini:2017:10.1002/ijc.30659,
author = {Caini, S and Masala, G and Saieva, C and Kvaskoff, M and Savoye, I and Sacerdote, C and Hemmingsson, O and Bech, BH and Overvad, K and Tjonneland, A and Petersen, KEN and Mancini, FR and Boutron-Ruault, M-C and Cervenka, I and Kaaks, R and Kuehn, T and Boeing, H and Floegel, A and Trichopoulou, A and Valanou, E and Kritikou, M and Tagliabue, G and Panico, S and Tumino, R and Bueno-de-Mesquita, HBA and Peeters, PH and Veierod, MB and Ghiasvand, R and Lukic, M and Ramon, Quiros J and Chirlaque, M-D and Ardanaz, E and Salamanca, Fernandez E and Larranaga, N and Zamora-Ros, R and Nilsson, LM and Ljuslinder, I and Jirstrom, K and Sonestedt, E and Key, TJ and Wareham, N and Khaw, K-T and Gunter, M and Huybrechts, I and Murphy, N and Tsilidis, KK and Weiderpass, E and Palli, D},
doi = {10.1002/ijc.30659},
journal = {International Journal of Cancer},
pages = {2246--2255},
title = {Coffee, tea and melanoma risk: findings from the European Prospective Investigation into Cancer and Nutrition},
url = {http://dx.doi.org/10.1002/ijc.30659},
volume = {140},
year = {2017}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - In vitro and animal studies suggest that bioactive constituents of coffee and tea may have anticarcinogenic effects against cutaneous melanoma; however, epidemiological evidence is limited to date. We examined the relationships between coffee (total, caffeinated or decaffeinated) and tea consumption and risk of melanoma in the European Prospective Investigation into Cancer and Nutrition (EPIC). EPIC is a multicentre prospective study that enrolled over 500,000 participants aged 25–70 years from ten European countries in 1992–2000. Information on coffee and tea drinking was collected at baseline using validated country-specific dietary questionnaires. We used adjusted Cox proportional hazards regression models to calculate hazard ratios (HR) and 95% confidence intervals (95% CI) for the associations between coffee and tea consumption and melanoma risk. Overall, 2,712 melanoma cases were identified during a median follow-up of 14.9 years among 476,160 study participants. Consumption of caffeinated coffee was inversely associated with melanoma risk among men (HR for highest quartile of consumption vs. non-consumers 0.31, 95% CI 0.14–0.69) but not among women (HR 0.96, 95% CI 0.62–1.47). There were no statistically significant associations between consumption of decaffeinated coffee or tea and the risk of melanoma among both men and women. The consumption of caffeinated coffee was inversely associated with melanoma risk among men in this large cohort study. Further investigations are warranted to confirm our findings and clarify the possible role of caffeine and other coffee compounds in reducing the risk of melanoma.
AU - Caini,S
AU - Masala,G
AU - Saieva,C
AU - Kvaskoff,M
AU - Savoye,I
AU - Sacerdote,C
AU - Hemmingsson,O
AU - Bech,BH
AU - Overvad,K
AU - Tjonneland,A
AU - Petersen,KEN
AU - Mancini,FR
AU - Boutron-Ruault,M-C
AU - Cervenka,I
AU - Kaaks,R
AU - Kuehn,T
AU - Boeing,H
AU - Floegel,A
AU - Trichopoulou,A
AU - Valanou,E
AU - Kritikou,M
AU - Tagliabue,G
AU - Panico,S
AU - Tumino,R
AU - Bueno-de-Mesquita,HBA
AU - Peeters,PH
AU - Veierod,MB
AU - Ghiasvand,R
AU - Lukic,M
AU - Ramon,Quiros J
AU - Chirlaque,M-D
AU - Ardanaz,E
AU - Salamanca,Fernandez E
AU - Larranaga,N
AU - Zamora-Ros,R
AU - Nilsson,LM
AU - Ljuslinder,I
AU - Jirstrom,K
AU - Sonestedt,E
AU - Key,TJ
AU - Wareham,N
AU - Khaw,K-T
AU - Gunter,M
AU - Huybrechts,I
AU - Murphy,N
AU - Tsilidis,KK
AU - Weiderpass,E
AU - Palli,D
DO - 10.1002/ijc.30659
EP - 2255
PY - 2017///
SN - 0020-7136
SP - 2246
TI - Coffee, tea and melanoma risk: findings from the European Prospective Investigation into Cancer and Nutrition
T2 - International Journal of Cancer
UR - http://dx.doi.org/10.1002/ijc.30659
UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000399313200008&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
UR - http://hdl.handle.net/10044/1/48360
VL - 140
ER -